Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.66% | 134.03 | 0.7% | $2124.95m | |
| PFE | Pfizer Inc. | 2.31% | 33.63 | 0.9% | $1411.52m | |
| MRK | Merck & Co., Inc. | -0.70% | 76.33 | 0.7% | $1270.98m | |
| ABBV | AbbVie, Inc. | -2.38% | 73.34 | 2.3% | $1177.90m | |
| BMY | Bristol-Myers Squibb Co. | 0.63% | 55.56 | 1.0% | $1081.19m | |
| LLY | Eli Lilly & Co. | -1.89% | 139.50 | 1.1% | $890.49m | |
| NVS | Novartis AG | 0.04% | 83.63 | 0.2% | $307.27m | |
| AZN | AstraZeneca Plc | 0.46% | 43.96 | 1.2% | $292.54m | |
| GSK | GlaxoSmithKline Plc | -1.54% | 37.12 | 0.2% | $251.81m | |
| FTSV | Forty Seven, Inc. | 0.03% | 95.46 | 0.0% | $173.71m | |
| NVO | Novo Nordisk A/S | 0.86% | 59.82 | 0.1% | $170.40m | |
| SNY | Sanofi | 3.03% | 44.83 | 0.2% | $169.69m | |
| BHC | Bausch Health Cos., Inc. | -2.14% | 13.29 | 0.0% | $88.41m | |
| RARX | Ra Pharmaceuticals, Inc. | -0.03% | 48.00 | 0.8% | $84.78m | |
| RGEN | Repligen Corp. | 1.30% | 98.21 | 7.1% | $74.31m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.